National Center for Advancing Translational Sciences; Notice of Online Forum, 106-107 [2021-28415]

Download as PDF 106 Federal Register / Vol. 87, No. 1 / Monday, January 3, 2022 / Notices Dated: December 27, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings [FR Doc. 2021–28408 Filed 12–30–21; 8:45 am] National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES National Institutes of Health Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS–NIH–CDC–SBIR PHS 2021–1 Phase I: Production of Adjuvants Mimics (Topic 106) (For SBIRs Phase I). Date: January 28, 2022. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20892 (Virtual Meeting). Contact Person: Margaret A. Morris Fears, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20852, (301) 761–5444, maggie.morrisfears@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS–NIH–CDC–SBIR PHS 2021–1 Phase II: Production of Adjuvants Mimics (Topic 106) (For SBIRs Phase II). Date: January 28, 2022. Time: 12:30 p.m. to 6:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20892 (Virtual Meeting). Contact Person: Margaret A. Morris Fears, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20852, (301) 761–5444, maggie.morrisfears@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Sep<11>2014 17:14 Dec 30, 2021 Jkt 256001 BILLING CODE 4140–01–P National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional). Date: February 7, 2022. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G33B, Rockville, MD 20892 (Virtual Meeting). Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G33B, Rockville, MD 20852, (301) 435–2398, pughjohn@ csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIH/NIAID 101 Novel Platforms for Delivery and/or Expression of HIV Env Immunogens for HIV Vaccines (N01). Date: January 26, 2022. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G33B, Rockville, MD 20892 (Virtual Meeting). Contact Person: John C. Pugh, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G33B, Rockville, MD 20852, (301) 435–2398, pughjohn@ csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 27, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–28409 Filed 12–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Dated: December 27, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. National Center for Advancing Translational Sciences; Notice of Online Forum [FR Doc. 2021–28410 Filed 12–30–21; 8:45 am] AGENCY: BILLING CODE 4140–01–P HHS. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\03JAN1.SGM National Institutes of Health, 03JAN1 Federal Register / Vol. 87, No. 1 / Monday, January 3, 2022 / Notices ACTION: Notice. The National Center for Advancing Translational Sciences (NCATS) will host a public online forum to enable public discussion of the Center’s proposals to reorganize its Office of Rare Diseases Research and Office of Grants Management and Scientific Review to the Division of Rare Diseases Innovation and the Division of Extramural Activities, respectively. The proposals seek to recognize the importance of rare diseases research to the Center and to align its extramural activities with those of other Institutes and Centers at the National Institutes of Health. The online forum will allow members of the public to review the reorganization proposals and submit comments. SUMMARY: The public online forum will become available on January 24, 2022 and will remain open for five calendar days, through January 29, 2022. ADDRESSES: The public forum will be held online, at https://ncats.nih.gov/ about/center/proposed-reorganization for the period of time listed above. FOR FURTHER INFORMATION CONTACT: Christopher Maurer, Management Analyst, National Center for Advancing Translational Sciences, NIH, christopher.maurer2@nih.gov or 301– 827–7280. SUPPLEMENTARY INFORMATION: The NIH Reform Act of 2006 (42 U.S.C. Sec. 281(d)(4)) requires public notice of proposed reorganization plans. This announcement and the public forum serve as that notice. DATES: Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Biochemistry and Biophysics of Membranes Study Section. Date: February 2–3, 2022. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nuria E Assa-Munt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 20892, (301) 451– 1323, assamunu@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Biology and Development of the Eye Study Section. Date: February 3–4, 2022. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Thomas Beres, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7840, Bethesda, MD 20892, 301–435– 1175, berestm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Keith R. Lamirande, Executive Officer, National Center for Advancing Translational Sciences. Dated: December 27, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–28415 Filed 12–30–21; 8:45 am] [FR Doc. 2021–28380 Filed 12–30–21; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HOMELAND SECURITY National Institutes of Health Coast Guard Center for Scientific Review; Notice of Closed Meetings khammond on DSKJM1Z7X2PROD with NOTICES and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, VerDate Sep<11>2014 17:14 Dec 30, 2021 Jkt 256001 [Docket No. USCG–2020–0278] Port Access Route Study: Northern New York Bight Coast Guard, DHS. Notice of availability; final AGENCY: ACTION: report. The First Coast Guard District announces the completion of the Northern New York Bight Port Access Route Study (NNYBPARS). The study was conducted to evaluate the adequacy of existing vessel routing measures and SUMMARY: PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 107 determine whether additional vessel routing measures are necessary for port approaches to New York and New Jersey and international and domestic transit areas in the First Coast Guard District’s area of responsibility. To accomplish this goal, the First Coast Guard District has undertaken measures to determine whether existing or additional routing measures are necessary to improve navigation safety due to factors such as planned or potential offshore development, current port capabilities and planned improvements, increased vessel traffic, existing and potential anchorage areas, changing vessel traffic patterns, effects of weather, or navigational difficulty. The NNYBPARS final report is available for viewing and download from the Federal Register docket at https://www.regulations.gov or the Coast Guard Navigation Center website at https:// www.navcen.uscg.gov/ ?pageName=PARSReports. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, contact Mr. Craig Lapiejko, Waterways Management at First Coast Guard District, telephone (617) 223–8351, email craig.d.lapiejko@uscg.mil. I. Table of Abbreviations DHS Department of Homeland Security LNM Local Notice to Mariners MSIB Marine Safety Information Bulletin MTS Marine Transportation System NAD 83 North American Datum of 1983 NNYB Northern New York Bight PARS Port Access Route Study PWSA Ports and Waterways Safety Act TSS Traffic Separation Scheme USCG United States Coast Guard II. Background and Purpose When did the Coast Guard conduct this Port Access Route Study (PARS)? We conducted this PARS following our announcement of the PARS in a notice published in the Federal Register on June 29, 2020, entitled ‘‘Port Access Route Study (PARS): Northern New York Bight,’’ (85 FR 38907). The public was afforded a 60-day comment period, and two virtual public meetings were held via teleconference and webinar to receive public input. The Coast Guard received 25 comments in response to our Federal Register Notice, public meetings and other outreach efforts, which included announcement via a Marine Safety Information Bulletin (MSIB), publication in the Local Notice to Mariners (LNM), and Facebook and Twitter posts. All comments and supporting documents to this document are available in a public docket and can be viewed at https:// www.regulations.gov. E:\FR\FM\03JAN1.SGM 03JAN1

Agencies

[Federal Register Volume 87, Number 1 (Monday, January 3, 2022)]
[Notices]
[Pages 106-107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28415]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Online Forum

AGENCY: National Institutes of Health, HHS.

[[Page 107]]


ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Center for Advancing Translational Sciences 
(NCATS) will host a public online forum to enable public discussion of 
the Center's proposals to reorganize its Office of Rare Diseases 
Research and Office of Grants Management and Scientific Review to the 
Division of Rare Diseases Innovation and the Division of Extramural 
Activities, respectively. The proposals seek to recognize the 
importance of rare diseases research to the Center and to align its 
extramural activities with those of other Institutes and Centers at the 
National Institutes of Health. The online forum will allow members of 
the public to review the reorganization proposals and submit comments.

DATES: The public online forum will become available on January 24, 
2022 and will remain open for five calendar days, through January 29, 
2022.

ADDRESSES: The public forum will be held online, at https://ncats.nih.gov/about/center/proposed-reorganization for the period of 
time listed above.

FOR FURTHER INFORMATION CONTACT: Christopher Maurer, Management 
Analyst, National Center for Advancing Translational Sciences, NIH, 
[email protected] or 301-827-7280.

SUPPLEMENTARY INFORMATION: The NIH Reform Act of 2006 (42 U.S.C. Sec. 
281(d)(4)) requires public notice of proposed reorganization plans. 
This announcement and the public forum serve as that notice.

Keith R. Lamirande,
Executive Officer, National Center for Advancing Translational 
Sciences.
[FR Doc. 2021-28415 Filed 12-30-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.